Medico Intercontinental reported a standalone net profit of ₹60.76 lakh for the quarter ended June 30, 2026 (Q1FY27), an increase from the ₹55.60 lakh recorded in the corresponding period of FY25. The company’s standalone revenue from operations stood at ₹1,524.02 lakh, up from ₹1,370.86 lakh in Q1FY26.

The Board of Directors approved the unaudited financial results at its meeting held on August 14, 2026. The statutory auditors expressed an unmodified opinion on these results under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Standalone earnings per share (EPS) were ₹0.61, compared to ₹0.56 in the same quarter last year. In the preceding quarter (Q4FY26), the company posted a net profit of ₹42.41 lakh on revenue of ₹1,655.31 lakh.

Consolidated results presented a different picture, with the group reporting a net loss of ₹404.23 lakh for the quarter, widening from the ₹248.80 lakh loss in Q1FY26. Consolidated revenue was ₹2,084.49 lakh, slightly down from ₹2,161.79 lakh in the prior year period.

What the Numbers Show

A significant divergence exists between the standalone and consolidated performance. While the parent entity generated a modest profit, the consolidated group incurred a substantial loss of ₹404.23 lakh despite higher consolidated revenues. This suggests that subsidiaries or associates within the group are currently operating at a loss, dragging down the overall group profitability despite the standalone unit's positive contribution.

Medico Intercontinental Limited disclosed that its Promoter and Managing Director, Samir Dilipkumar Shah, has increased his stake in the company through open market purchases. The acquisition of 1,36,886 equity shares took place between June 3 and June 24, 2026, as per a regulatory filing submitted on June 25, 2026. The disclosure was made in compliance with Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Following the transaction, Shah's total shareholding in the company rose to 47,76,999 equity shares, which constitutes 47.77% of the paid-up share capital. Prior to the acquisition, he held 46,40,113 shares, accounting for 46.40% of the company. The shares were acquired exclusively on the BSE.

Details of Acquisition

The table below outlines the specific transactions executed by the promoter during the specified period:

The filing confirmed that there were no transactions in derivatives by the promoter during this period. The company stated that the value of the transactions excludes taxes, brokerage, and other charges. Puneeta Sharma, Company Secretary and Compliance Officer, submitted the disclosure to the stock exchanges.